臨床化学分析装置の市場規模、シェア、動向分析レポート：製品別、検査別、最終用途別、地域別、セグメント別予測、2024年～2030年

臨床化学分析装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床化学分析装置市場規模は2024年から2030年にかけてCAGR 4.7%で拡大し、2030年には258億8,000万米ドルに達する見込みです。

慢性疾患の増加により、臨床化学分析装置の導入が急務となっており、予測期間中の成長余地が広がっています。加えて、慢性疾患に罹患しやすい高齢者や肥満人口の増加も需要を押し上げるとみられます。その結果、高い能力を持つ分析装置を必要とするサンプル量が多くなり、市場成長の原動力となっています。

さらに、臨床化学分析装置の利点に対する認識が高まっていることも、市場促進要因となっています。先進的な化学分析装置の登場により、ポイントオブケアでの検査能力が向上し、市場の潜在成長機会が高まっています。加えて、分析前、分析、分析後の各段階における分析装置や試薬の技術的進歩により、診断能力と全体的な効率が向上しました。これらの進歩には、マイクロチップ、センサー、ケモメトリックス、ロボット工学の出現が含まれます。さらに、データの信頼性を高めるための公的機関や民間医療機関の一貫した取り組みにより、自動化学分析装置と免疫測定システムの統合が急速に進み、その結果、検査室の作業負荷が全体的に軽減され、需要が高まっています。

臨床化学分析装置市場のハイライト

• 製品別では、試薬セグメントが2023年に57.4%の最大売上シェアで市場をリードしました。この大幅なシェアは、臨床医のさまざまな要求に応える幅広い試薬が市場に存在する結果と予測されます。
• 検査タイプ別では、基礎代謝パネル（BMP）セグメントが2023年に29.56％の最大売上シェアを占めました。
• 最終用途別では、病院分野が2023年に58.32％の最大収益シェアで市場をリードしました。
• 北米は、米国などの国におけるヘルスケア支出の増加により、2023年に35.6%の収益シェアで市場を独占しました。
• アジア太平洋地域は、対象人口が多く、インドや中国などの国々で主要な臨床化学製品メーカーの浸透が進んでいることから、予測期間中に最も速いCAGRで成長すると予測されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床化学分析装置の市場変数、動向および範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 臨床化学分析装置市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 価格分析

第4章 臨床化学分析装置市場：製品の推定・動向分析

• 製品の市場シェア、2023年と2030年
• セグメントダッシュボード
• 製品別の世界の臨床化学分析装置市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第5章 臨床化学分析装置市場：検査の推定・動向分析

• 市場シェアのテスト、2023年と2030年
• セグメントダッシュボード
• 検査別の世界の臨床化学分析装置市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第6章 臨床化学分析装置市場：最終用途の推定・動向分析

• 最終用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 最終用途別の世界の臨床化学分析装置市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第7章 臨床化学分析装置市場：地域の推定・動向分析

• 地域の市場シェア分析、2024年および2030年
• 地域の市場ダッシュボード
• 世界の地域の市場スナップショット
• 市場規模と予測の動向分析、2018年から2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
• ベンダー情勢
  • Mindray Medical International Limited
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation（Beckman Coulter）
  • Abbott Laboratories
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Horiba, Ltd.
  • Elitech Group
  • Ortho Clinical Diagnostics
  • Randox Laboratories

List of Tables

• Table 1 List of abbreviation
• Table 2 North America clinical chemistry analyzers market, by region, 2018 - 2030 (USD Million)
• Table 3 North America clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 4 North America clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 5 North America clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 6 U.S. clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 8 U.S. clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 9 Canada clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 11 Canada clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 12 Europe clinical chemistry analyzers market, by region, 2018 - 2030 (USD Million)
• Table 13 Europe clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 14 Europe clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 15 Europe clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 16 Germany clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 17 Germany clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 18 Germany clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 19 UK clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 20 UK clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 21 UK clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 22 France clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 23 France clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 24 France clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 25 Italy clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 26 Italy clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 27 Italy clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 28 Spain clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 29 Spain clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 30 Spain clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 31 Denmark clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 32 Denmark clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 33 Denmark clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 34 Sweden clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 35 Sweden clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 36 Sweden clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 37 Norway clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 38 Norway clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 39 Norway clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific clinical chemistry analyzers market, by region, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 44 China clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 45 China clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 46 China clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 47 Japan clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 48 Japan clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 49 Japan clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 50 India clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 51 India clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 52 India clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 53 South Korea clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 54 South Korea clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 55 South Korea clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 56 Australia clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 57 Australia clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 58 Australia clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 59 Thailand clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 60 Thailand clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 61 Thailand clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 62 Latin America clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 63 Latin America clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 64 Latin America clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 65 Brazil clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 66 Brazil clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 67 Brazil clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 68 Mexico clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 69 Mexico clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 70 Mexico clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 71 Argentina clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 72 Argentina clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 73 Argentina clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 74 Colombia clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 75 Colombia clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 76 Colombia clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 77 Peru clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 78 Peru clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 79 Peru clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 80 MEA clinical chemistry analyzers market, by region, 2018 - 2030 (USD Million)
• Table 81 MEA clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 82 MEA clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 83 MEA clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 84 South Africa clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 85 South Africa clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 86 South Africa clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 89 Saudi Arabia clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 90 UAE clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 91 UAE clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 92 UAE clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)
• Table 93 Kuwait clinical chemistry analyzers market, by product, 2018 - 2030 (USD Million)
• Table 94 Kuwait clinical chemistry analyzers market, by test, 2018 - 2030 (USD Million)
• Table 95 Kuwait clinical chemistry analyzers market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Clinical Chemistry Analyzers Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Clinical Chemistry Analyzers Market snapshot (2023)
• Fig. 9 Clinical Chemistry Analyzers Market: Segment snapshot (2023)
• Fig. 10 Competitive Insights (2023)
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Clinical Chemistry Analyzers Market driver impact
• Fig. 15 Clinical Chemistry Analyzers Market restraint impact
• Fig. 16 Clinical chemistry industry challenges
• Fig. 17 Porter's Five Forces Analysis
• Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
• Fig. 19 Strategic alliance analysis
• Fig. 20 Recent developments & impact analysis, by key market participants
• Fig. 21 Key company market share analysis, 2023
• Fig. 22 Company market position analysis
• Fig. 23 Definition and scope, by product
• Fig. 24 Product market share analysis, 2023 & 2030
• Fig. 25 Segment dashboard
• Fig. 26 Global Clinical Chemistry Analyzers Market, by product, 2018 - 2030 (USD Million)
• Fig. 27 Analyzers market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 28 Small market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 29 Medium market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 30 Large market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 31 Very large market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 32 Reagents market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 33 Calibrators market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 34 Controls market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 35 Standards market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 36 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 37 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 38 Definition and scope, by test
• Fig. 39 Test market share analysis, 2023 & 2030
• Fig. 40 Segment dashboard
• Fig. 41 Global Clinical Chemistry Analyzers Market, by test, 2018 - 2030 (USD Million)
• Fig. 42 Basic metabolic panel (BMP) market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 43 Electrolyte panel market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 44 Liver panel market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 45 Lipid profile market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 46 Renal profile market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 47 Thyroid function panel market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 48 Specialty chemical tests market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 49 Definition and scope, by end-use
• Fig. 50 End-use market share analysis, 2023 & 2030
• Fig. 51 Segment dashboard
• Fig. 52 Global Clinical Chemistry Analyzers Market, by end-use, 2018 - 2030 (USD Million)
• Fig. 53 Hospitals market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 54 Academic research centers market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 55 Diagnostic laboratories and market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 56 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 57 Clinical Chemistry Analyzers Market: Snapshot, 2023
• Fig. 58 North America Clinical Chemistry Analyzers Market share and leading players, 2023
• Fig. 59 Europe Clinical Chemistry Analyzers Market share and leading players, 2023
• Fig. 60 Asia Pacific Clinical Chemistry Analyzers Market share and leading players, 2023
• Fig. 61 Latin America Clinical Chemistry Analyzers Market share and leading players, 2023
• Fig. 62 Middle East and Africa Clinical Chemistry Analyzers Market share and leading players, 2023
• Fig. 63 North America market share analysis by country, 2023
• Fig. 64 Europe market share analysis by country, 2023
• Fig. 65 Asia Pacific market share analysis by country, 2023
• Fig. 66 Latin America market share analysis by country, 2023
• Fig. 67 Middle East and Africa market share analysis by country, 2023
• Fig. 68 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 69 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 70 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 71 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 72 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 73 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 74 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 75 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 76 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 77 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 78 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 79 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 80 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 81 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 82 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 83 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 84 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 85 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 86 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 87 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 88 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 89 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 90 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
• Fig. 91 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 92 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 93 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 94 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
• Fig. 95 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)

Clinical Chemistry Analyzers Market Growth & Trends:

The global clinical chemistry analyzers market size is expected to reach USD 25.88 billion by 2030, expanding at a CAGR of 4.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of chronic diseases is anticipated to be responsible for the high urgency to adopt clinical chemistry analyzers, which thereby widens the scope for growth during the forecast period. In addition, growing base of geriatric and bariatric population, which is highly susceptible to chronic diseases, is presumed to impel the demand further. Consequently, the resultant high sample volume requiring high capability analyzing devices is driving the market growth.

Moreover, increasing awareness pertaining to benefits associated with these devices is also a high impact rendering driver for clinical chemistry analyzers market. Advent of advanced chemistry analyzers has resulted in improved point-of-care testing capabilities, and thus created high potential growth opportunities for the market. In addition, technological advancements in preanalytical, analytical, and post analytical stages due to analyzing devices & reagents improved their diagnostic capabilities and overall efficiency, which is predicted to propel the growth further. These advancements include advent of microchips, sensors, chemometrics, and robotics. Furthermore, consistent efforts by public as well private healthcare organizations to increase the reliability of data have rapidly engendered the integration of automated chemistry analyzers and immunoassay systems, thereby resulting in overall reduction of workload in laboratories, thus propelling the demand.

Clinical Chemistry Analyzers Market Report Highlights:

• Based on product, the reagents segment led the market with the largest revenue share of 57.4% in 2023. The substantial share is predicted to be a consequence of a wide array of reagents present in the market, catering to different requirements of clinicians.
• Based on the test type, the basic metabolic panel (BMP) segment held a market with the largest revenue share of 29.56% in 2023, owing to growing prevalence of lifestyle-induced diseases, such as obesity and other metabolic abnormalities.
• Based on end-use, the hospitals segment led the market in 2023 with the largest revenue share of 58.32%, owing to the high patient volume, frequent readmissions, and large sample volumes.
• North America dominated the market with the revenue share of 35.6% in 2023, due to rising healthcare spending in country, such as the U.S.
• Asia Pacific region is anticipated to grow at the fastest CAGR during the forecast period owing to the presence of a large target population and increasing penetration of leading clinical chemistry product manufacturers in countries, such as India and China.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Test
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Test Outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Chemistry Analyzers Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increase in laboratory automation
    • 3.2.1.2. Increasing prevalence of chronic diseases
    • 3.2.1.3. Increase in technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Requirement of high capital investments
    • 3.2.2.2. Stringent regulatory scenario
• 3.3. Clinical Chemistry Analyzers Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Pricing Analysis

Chapter 4. Clinical Chemistry Analyzers Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Clinical Chemistry Analyzers Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Analyzers
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.2. Small
    • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.3. Medium
    • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.4. Large
    • 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.1.5. Very Large
    • 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Reagents
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.2. Calibrators
    • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.3. Controls
    • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.4. Standards
    • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2.5. Others
    • 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Others
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Chemistry Analyzers Market: Test Estimates & Trend Analysis

• 5.1. Test Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Clinical Chemistry Analyzers Market by Test Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Basic Metabolic Panel
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Electrolyte Panel
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Liver Panel
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Lipid Profile
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Renal Profile
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Thyroid Function Panel
    • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Specialty Chemical Tests
    • 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Chemistry Analyzers Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Clinical Chemistry Analyzers Market by End Use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Hospitals
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Academic Research Centers
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Diagnostic Laboratories
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Others
    • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Clinical Chemistry Analyzers Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Mexico
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. Mindray Medical International Limited
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Thermo Fisher Scientific, Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Danaher Corporation (Beckman Coulter)
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Abbott Laboratories
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Siemens Healthineers
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. F. Hoffmann-La Roche
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Horiba, Ltd.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Elitech Group
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Ortho Clinical Diagnostics
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Randox Laboratories
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives